Home › Osteosarcoma › Florida › St. Petersburg
Osteosarcoma clinical trials in St. Petersburg, FL
3 studies for Osteosarcoma are looking for participants at sites in and around St. Petersburg (within about 30 miles). Open a study to see who can join and how to contact the study team.
Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor
RecruitingPhase 2
- Johns Hopkins All Children's Hospital, St. Petersburg
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
RecruitingPhase 1/2
- All Children's Hospital Johns Hopkins Medicine, St. Petersburg
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
RecruitingPhase 3
- Johns Hopkins All Children's Hospital, St. Petersburg
Osteosarcoma trials in other cities
- Memphis, TN10 studies
- St. Louis, MO10 studies
- Atlanta, GA10 studies
- Boston, MA9 studies
- Mountain View, CA8 studies
- Houston, TX7 studies
- Chicago, IL7 studies
- Birmingham, AL7 studies
- Los Angeles, CA7 studies
- Tampa, FL6 studies
- Washington, DC6 studies
- Aurora, CO6 studies
Other studies in St. Petersburg
- Non-Small Cell Lung Cancer21 studies
- Breast Cancer11 studies
- Obesity9 studies
- Overweight9 studies
- Colorectal Cancer8 studies
- Heart Failure8 studies
- Lung Cancer7 studies
- Ovarian Cancer6 studies
- Burkitt Lymphoma6 studies
- Endometrial Cancer6 studies
- Type 2 Diabetes5 studies
- Cancer (all types)5 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.